Assessing quality of life in patients with bronchiectasis using oscillating PEP devices

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the quality of life and adherence to treatment in children and adults with bronchiectasis who are not currently using oscillating positive expiratory pressure (PEP) devices. Participants will complete various questionnaires to assess their quality of life before and after the introduction of the oscillating PEP device. The goal is to determine how this device impacts their daily lives and overall well-being. The study will include clinically stable patients who are regularly followed up in consultations.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Children (from 8 years of age) and adults over 18 years of age with DDB who doesn't use oscillating PEP.

The study population will be clinically stable and will be seen in follow-up consultations.

Exclusion Criteria:

* Children under 8 years of age.
* Patients who use an OPEP
* Patients in the acute exacerbation phase of their DDB
* Patients who are not under regular consultation
* Patients with severe, uncontrolled co-morbidities
* Patients with cognitive or psychiatric disorders preventing proper adherence to the study protocol
* Patients taking part simultaneously in another clinical study that could interfere with the results of the OPEP study

Where it's running

• CHU Amiens-Picardie
  Amiens, France Recruiting

Study contacts

• Study coordinator: Thomas PINTO, MD
• Email: pinto.thomas@chu-amiens.fr
• Phone: 33+3 22 08 80 00

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Chronic Respiratory Disease Participant Engagement

  This study tests whether adults with long-term lung conditions can get comfortable with a clinical trials unit and research team before joining future trials.

  Recruiting Richmond Pharmacology Limited · London · NCT07924462

• Breathlessness in respiratory diseases: who feels it and why

  This study tests how physiology, psychology, function, and breathing patterns relate to breathlessness in people with respiratory conditions compared with healthy controls.

  Recruiting University Hospitals, Leicester · Leicester, Leicestershire · NCT07648082

• Hypertonic saline inhalation for NTM lung disease

  This trial tests whether starting inhaled 3% hypertonic saline early helps people with non-tuberculous mycobacterial lung disease feel better and clear bacteria better, compared with starting with normal saline first.

  Recruiting Taipei Veterans General Hospital, Taiwan · Taipei · NCT07647575

• Balance and gait in multiple sclerosis: linking motion data to function

  Researchers will see if precise motion measurements of balance and walking relate to everyday functional tests in adults with MS.

  Recruiting at 2 sites University of Patras · Ioannina and 1 other locations · NCT07630311

• Azithromycin added to usual care to see if it lowers bronchiectasis flare-ups

  This trial tests whether taking azithromycin daily for a year reduces bronchiectasis-related flare-ups in adults with non-cystic fibrosis bronchiectasis.

  Recruiting Phase 4 Assiut University · Asyut · NCT07608328

• Bronchiectasis Phenotype Identification Model for Adults

  This study tests a baseline classifier to categorize adults with non-cystic fibrosis bronchiectasis into phenotype groups using data collected over time.

  Recruiting Assiut University · Asyut, Assiut Egypt · NCT07599969

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.